
Editas Medicine (EDIT) Expected to Announce Earnings on Wednesday
Editas Medicine (NASDAQ:EDIT – Get Free Report) is projected to announce its Q4 2025 results before the market opens on Wednesday, March 4th. Analysts expect Editas Medicine to post earnings of ($0.27) per share and revenue of $8.7680 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the [...]




